Claims for Patent: 4,185,084

Summary for Patent: 4,185,084

Title:	Immunochemical measuring method using second antigenic substance
Abstract:	An immunochemical measuring method using a second antigenic substance and a labeled antibody to the second antigenic substance. An unknown amount of an antigen (Ag 1) to be measured and a given amount of a conjugate (Ag 1-Ag 2) coupled a second antigen (Ag 2) to the Ag 1 are reacted with a given amount of an antibody (Ab 1) to the Ag 1. Ag 1-Ag 2 bind to the Ab 1 in proportion to their respective amount, forming an Ab 1-Ag 1-Ag 2 complex. Then, by reaction of the complex with a labeled antibody (labeled Ab 2) to the Ag 2, Ab 1-Ag 1-Ag 2-labeled Ab 2 is formed. It is possible to estimate the amount of Ag 1 to be measured by determining the activity of labeled Ab 2 attached to the complex.
Inventor(s):	Mochida; Ei (Tokyo, JP), Ogawa; Nobuhisa (Omiya, JP), Shinkai; Hiroyuki (Kawagoe, JP), Hashimoto; Masakatsu (Tokyo, JP)
Assignee:	Mochida Seiyaku Kabushiki Kaisha (Tokyo, JP)
Application Number:	05/838,846
Patent Claims:	1. An immunochemical measuring method comprising the steps of (a) reacting an antibody to an antigen to be measured (Ab 1) with an antigen to be measured (Ag 1) and a conjugate coupled with said antigen to be measured to a second antigen having strong antigenicity (Ag 1-Ag 2), (b) separating the Ab 1-Ag 2 complex produced by the above reaction from the reaction mixture, (c) reacting the separated Ab 1-Ag 1-Ag 2 complex with a labeled antibody to the second antigen (Ab 2), (d) separating the reaction products of Ab 1-Ag 1-Ag 2-labeled Ab 2 complex produced by the above reaction from the reaction mixture, and (e) measuring either the activity of a labeling agent bound to the above reaction products or of a labeling agent remaining in the reaction mixture. 2. Immunochemical measuring method of claim 1, wherein the antigen to be measured is selected from the group consisting of low molecular substances, relatively low molecular substances and high molecular substances. 3. Immunochemical measuring method of claim 1, wherein the second antigen is selected from the group consisting of bovin serum albumin, human serum albumin, rabbit .gamma.-globulin, human chorionic gonadotropin, hemoglobin, tetanus toxoid, pneumococcal polysaccharide or glutamic acidlysinetyrosine copolymer. 4. Immunochemical measuring method of claim 1, wherein the labeling agent is selected from the group consisting of radioisotope, enzyme or fluorescent material. 5. Reagent for immunochemical measurement, comprising a bindable substance which specifically binds to a substance to be measured; an antigen conjugate of the substance to be measured which has been bound to a substance having high antigenicity; and a labeled antibody of the substance having high antigenicity. 6. The reagent for immunochemical measurement of claim 5, wherein the substance to be measured include a low molecular substances, relatively low molecular substances and high molecular substances. 7. The reagent for immunochemical measurement of claim 5, wherein the substance having high antigenicity is bovine serum albumin, human serum albumin, .gamma.-globulin, human chorionic gonadotropin, hemoglobin, tetanus toxoid, pneumococcal polysaccharide or glutamic acid-lysine-tyrosine copolymer. 8. The reagent for immunochemical measurement of claim 5, wherein the labeling agent is radioisotope, enzyme or fluorescent material. 9. The reagent for immunochemical measurement of claim 5, wherein the bindable substance, the antigen conjugate and the labeled antibody are lyophilized.

Details for Patent 4,185,084

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Ferring Pharmaceuticals Inc.	NOVAREL	chorionic gonadotropin	For Injection	017016	01/15/1974		1997-01-22
Ferring Pharmaceuticals Inc.	NOVAREL	chorionic gonadotropin	For Injection	017016	12/27/1984		1997-01-22
Ferring Pharmaceuticals Inc.	NOVAREL	chorionic gonadotropin	For Injection	017016	02/15/1985		1997-01-22
Ferring Pharmaceuticals Inc.	NOVAREL	chorionic gonadotropin	For Injection	017016	02/16/1990		1997-01-22
Bel-mar Laboratories, Inc.	CHORIONIC GONADOTROPIN	chorionic gonadotropin	Injection	017054	03/26/1974		1997-01-22
Fresenius Kabi Usa, Llc	CHORIONIC GONADOTROPIN	chorionic gonadotropin	For Injection	017067	03/05/1973		1997-01-22